BARBARA BASILE: Open Payments
NPI 1558135772 · WOODBURY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$382 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $746 · 2025 $382
Food & beverage: $382
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $123 |
| E.R. Squibb & Sons, L.L.C. | 1 | $84 |
| Axsome Therapeutics, Inc. | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
Products named: VRAYLAR, COBENFY, Auvelity, REXULTI, FANAPT, CAPLYTA, SPRAVATO, ABILIFY ASIMTUFII.
Industry payments across NJ — which companies pay providers there.
